Tango Therapeutics, Inc. Balance Sheet
TNGX / Health Care|6 years of annual SEC 10-K data (FY2020-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Tango Therapeutics, Inc. had $399M in total assets and $346M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $112.3M | $69.5M | $66.4M | $60.0M | $142.7M | $28.4M |
| Accounts Receivable | - | - | - | $2.0M | $2.0M | $2.0M |
| Current Assets | $353.8M | $266.3M | $346.5M | $375.3M | $492.3M | $193.6M |
| PP&E (Net) | $6.9M | $8.1M | $9.9M | $10.9M | $4.8M | $3.8M |
| Total Assets | $398.7M | $316.5M | $402.6M | $436.5M | $500.2M | $207.3M |
| Current Liabilities | $21.7M | $38.2M | $45.9M | $55.5M | $40.7M | $40.9M |
| Shareholders' Equity | $346.2M | $199.5M | $253.1M | $344.7M | $38.6M | $38.6M |